Guo J - Search Results

1

Carbon dot nanozymes as free radicals scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosis.

Geng H, Chen J, Tu K, Tuo H, Wu Q, Guo J, Zhu Q, Zhang Z, Zhang Y, Huang D, Zhang M, Xu Q. Geng H, et al. Among authors: guo j. J Nanobiotechnology. 2023 Dec 21;21(1):500. doi: 10.1186/s12951-023-02234-1. J Nanobiotechnology. 2023. PMID: 38129928 Free PMC article.

2

[The correlation of plasma thrombomodulin plasminogen activator inhibitor-1 and endothelial cell injury in septic patients].

Guo J, Xu QH. Guo J, et al. Zhonghua Nei Ke Za Zhi. 2021 Feb 1;60(2):143-146. doi: 10.3760/cma.j.cn112138-20200330-00319. Zhonghua Nei Ke Za Zhi. 2021. PMID: 33503726 Chinese.

3

HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.

Zeng Z, Shi Z, Liu Y, Zhao J, Lu Q, Guo J, Liu X, Huang D, Xu Q. Zeng Z, et al. Among authors: guo j. Biochem Biophys Res Commun. 2021 Aug 20;566:80-86. doi: 10.1016/j.bbrc.2021.06.011. Epub 2021 Jun 10. Biochem Biophys Res Commun. 2021. PMID: 34118595

4

LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis.

Liu Y, Liu R, Zhao J, Zeng Z, Shi Z, Lu Q, Guo J, Li L, Yao Y, Liu X, Xu Q. Liu Y, et al. Among authors: guo j. J Cancer. 2021 Sep 24;12(22):6805-6813. doi: 10.7150/jca.63351. eCollection 2021. J Cancer. 2021. PMID: 34659569 Free PMC article.

5

Case Report: Retroperitoneal Sarcoma in Six Operations: Our Experience in Operative Management of Blood Vessels.

Guo J, Qiu F, Zhao J, Lu Q, Fu W, Xu Q, Huang D. Guo J, et al. Front Oncol. 2022 Apr 28;12:885033. doi: 10.3389/fonc.2022.885033. eCollection 2022. Front Oncol. 2022. PMID: 35574413 Free PMC article.

6

Research Progress of DUB Enzyme in Hepatocellular Carcinoma.

Zhao J, Guo J, Wang Y, Ma Q, Shi Y, Cheng F, Lu Q, Fu W, Ouyang G, Zhang J, Xu Q, Hu X. Zhao J, et al. Among authors: guo j. Front Oncol. 2022 Jun 27;12:920287. doi: 10.3389/fonc.2022.920287. eCollection 2022. Front Oncol. 2022. PMID: 35875077 Free PMC article. Review.

7

Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.

Guo J, Zhao J, Fu W, Xu Q, Huang D. Guo J, et al. Front Immunol. 2022 Jul 20;13:918314. doi: 10.3389/fimmu.2022.918314. eCollection 2022. Front Immunol. 2022. PMID: 35935969 Free PMC article. Review.

8

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.

Hu X, Lei X, Guo J, Fu W, Sun W, Lu Q, Su W, Xu Q, Tu K. Hu X, et al. Among authors: guo j. Front Oncol. 2022 Jul 22;12:927640. doi: 10.3389/fonc.2022.927640. eCollection 2022. Front Oncol. 2022. PMID: 35936737 Free PMC article. Review.

9

Resistance of Lenvatinib in Hepatocellular Carcinoma.

Guo J, Zhao J, Xu Q, Huang D. Guo J, et al. Curr Cancer Drug Targets. 2022;22(11):865-878. doi: 10.2174/1568009622666220428111327. Curr Cancer Drug Targets. 2022. PMID: 36267045 Review.

10

Hypoxia-induced UBE2K promotes the malignant progression of HCC.

Ouyang G, Fu W, Guo J, Lu Q, Yao Y, Ge L, Zhao J, Zhang J, Hu X, Li S, Xu Q, Huang D, Zhang Y. Ouyang G, et al. Among authors: guo j. Pathol Res Pract. 2023 May;245:154422. doi: 10.1016/j.prp.2023.154422. Epub 2023 Mar 25. Pathol Res Pract. 2023. PMID: 37003132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29,083 results

Search Page